UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: January 16, 2025 4:30 P.M.
Form: S-3
CIK: 0001750149
Company Name: Inhibikase Therapeutics, Inc.
File Number: 333-284222